Showing 3004 results
-
Story /Novartis has reached the highest performance tier in the CCLA Corporate Mental Health Benchmark, recognizing a comprehensive approach to workplace mental health, wellbeing and employee support.
-
Biography /
-
Story /Novartis is working with community partners to bring heart disease and cancer screening, information and support closer to where people are.
-
Press release /In Phase III RemIND trial, twice as many adults taking Rhapsido achieved complete hive resolution by Week 12 vs placebo, with responses seen by Week 21SD is most prevalent type of chronic inducible…
-
Press release /Late-breaking data from positive Phase III REMODEL-1/-2 trials will show efficacy and safety profile of remibrutinib in RMS Novartis to hold virtual investor event highlighting REMODEL data and…
-
Story /Nazem Atassi, Development Unit Head for Neuroscience and Gene Therapies, Global Drug Development.
-
Clinical Trials /
-
Clinical Trials /
-
Event / Feb 03, 2027Novartis announces the company’s fourth quarter and 2026 full year financial results.
-
Event / Jan 11, 2027